Cognyte Secures $20 Million Expansion for AI-Driven National Security Analytics
The expansion introduces agentic decision flows to bolster investigative capabilities for a national security agency in the EMEA region.

For decades, the human brain has remained a labyrinth of intricate pathways, largely understood through static snapshots.
Traditional medical imaging, while invaluable, has offered only a partial glimpse, failing to fully capture the dynamic symphony of communication between different neural regions.
This fundamental blind spot has long hindered early detection of devastating neurological diseases, leaving patients and clinicians playing a frustrating game of catch-up.
But a profound shift is underway, spearheaded by innovators like Dr. Rahul Biswas, a neurologist at the University of California–San Francisco, whose pioneering work is harnessing the power of artificial intelligence to illuminate these once-hidden neural conversations.
Dr. Biswas, through his company Kaneva Consulting, is not just refining existing diagnostic tools; he is redefining the very lens through which we understand brain health. Brain health is essential for overall well-being.
His research is pulling back the curtain on how diseases like Alzheimer’s don’t just affect isolated memory centers, but orchestrate a far more widespread communication breakdown across the brain—a revelation challenging long-held scientific assumptions.
AI, in his hands, is transforming neuroscience from a discipline of isolated observations into one of holistic, systems-level understanding.
No longer are scientists confined to examining where activity happens; they are now tracing how regions interact, influence each other, and subtly change over time, uncovering patterns that conventional analysis simply couldn’t discern.
Imagine detecting a complex network of brain regions consistently collaborating during memory formation, a vital insight previously obscured by the sheer complexity of the data.
This shift from mere snapshots to a dynamic, interconnected view is precisely what AI enables.
The immediate implications are nothing short of revolutionary.
One of the most compelling applications is the early detection of neurodegenerative diseases. AI models can sift through vast quantities of brain scans, even routine health records, to pinpoint the most subtle harbingers of disease years before symptoms manifest.
Dr. Biswas cites compelling examples, such as machine learning systems detecting Alzheimer’s with over 90% accuracy on MRI scans years ahead of traditional diagnoses.
This capability is not merely academic; it means the potential for intervention at a stage when treatments could be far more effective, perhaps even preventing or significantly delaying the onset of debilitating symptoms.
Beyond detection, AI is poised to personalize treatment strategies, analyzing an individual’s unique neural and genetic data to predict which therapies will be most efficacious, thereby replacing the often frustrating trial-and-error approach common in current medical practice.
In practical terms, this AI-powered brain monitoring promises a level of personalized care previously unimaginable.
A patient undergoing an fMRI scan would have their data directly fed into an algorithm, generating a bespoke ‘brain network model.’
This model, unique to that individual, would allow clinicians to track the evolution of their brain’s intricate connections over time.
“Are they getting closer to signatures of Alzheimer’s or other neurological diseases? Or are they doing fine?” Dr. Biswas muses, explaining that deviations would be flagged much like an abnormal blood test result.
Just as a red mark might appear next to an elevated cholesterol level, a warning could emerge for a weakening neural network, recognizing these networks as potent biomarkers for disease prediction.
The vision extends beyond the clinic.
The fusion of AI with wearable technology promises to integrate continuous brain health monitoring seamlessly into our daily lives.
Our smartphones and smartwatches, already tracking sleep and heart rate, could, with AI analysis, become vigilant sentinels for cognitive decline or mental health issues.
A subtle shift in typing speed, a change in sleep patterns—these could become early warning signals, a “check engine light” for the brain, transforming brain health from an episodic doctor’s visit into a proactive, omnipresent concern.
What sets Dr. Biswas’s approach apart from traditional brain network analysis is its focus on causality. Naive methods might simply observe that two brain regions, A and B, are correlated and assume a direct connection.
But as Biswas explains, this could be a “spurious connection,” where a third region, C, is actually influencing both A and B.
His causal models delve deeper, seeking to establish genuine influence—who affects whom—providing a far more accurate map of information flow.
This rigorous methodology has yielded surprising discoveries, particularly in Alzheimer’s research.
Rather than a localized breakdown, Biswas’s team observed a widespread communication failure impacting not just the expected memory centers, but also parts of the frontal and temporal lobes, and even, surprisingly, the cerebellum—a region not typically associated with Alzheimer’s.
This hints at a far broader disruption than previously understood, alongside the intriguing observation of the brain’s own attempts to reroute signals through secondary pathways, a testament to its inherent resilience.
These findings carry profound practical implications.
By identifying specific networks that weaken early in Alzheimer’s, doctors could leverage these as biomarkers for earlier, more precise diagnosis.
Furthermore, this granular understanding opens the door for targeted therapies.
Imagine pinpointing the exact neural hubs or pathways breaking down and then focusing interventions—be it targeted brain stimulation or specific cognitive exercises—precisely where they are most needed.
In the next three to five years, Dr. Biswas envisions AI-analyzed scans detecting Alzheimer’s years before symptoms, brain connectivity becoming a new vital sign monitored over time to adjust therapies, and personalized, network-guided treatment plans tailored to an individual’s unique neural weaknesses.
The ripple effects of this research extend far beyond the medical realm.
Insights into the brain’s causal networks could inspire a new generation of smarter everyday technology.
AI software, for instance, could draw inspiration from how brain regions adapt and influence each other across different mental states, leading to digital assistants that are far more context-aware and responsive.
Brain-computer interfaces, which allow users to control devices with neural signals, could become significantly more intuitive and efficient by aligning with the brain’s natural information flow.
In essence, the brain is offering a blueprint for creating more efficient, user-friendly, and truly “brain-like” technological systems.
Dr. Biswas also challenges a common misconception: that the brain operates like a simple computer—input, processing in one place, output.
His research unequivocally demonstrates that the brain is a “dynamic web of interconnected regions constantly influencing one another,” where even a simple decision involves complex, causal chains, adapting and rerouting in context-dependent ways.
This holistic view, enabled by AI, allows neuroscientists to ask system-level questions previously deemed impossible or impractical, such as how signals propagate across the entire brain or how networks reorganize under stress or disease.
To ensure AI delivers on its immense promise for brain health, Dr. Biswas offers a singular, crucial piece of advice for healthcare leaders and policymakers: prioritize building a robust foundation of data and validation.
This means fostering secure sharing of high-quality, diverse brain health data across institutions to train powerful AI models.
Crucially, it also entails demanding rigorous testing—akin to clinical trials for algorithms—before these AI tools are deployed in clinical settings.
Only with rich, representative data and stringent validation can we ensure that AI truly ushers in safe, effective improvements in brain health, rather than merely generating hype.
The journey from static snapshots to dynamic, causal maps of the brain is not just a scientific endeavor; it is a profound step towards a future where brain health is proactively understood, protected, and optimized for every individual.
The expansion introduces agentic decision flows to bolster investigative capabilities for a national security agency in the EMEA region.
Zoho founder Sridhar Vembu warns that companies must prioritize data sovereignty by building internal AI models to protect sensitive intellectual property.
Cities are deploying artificial intelligence on sanitation vehicles to monitor private property, raising complex questions about the future of urban privacy and municipal oversight.